|
HMMR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.99360577730113E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.95810001335906E-09 |
| Normal-vs-Stage2 |
8.858300E-02 |
| Normal-vs-Stage3 |
3.717999999997E-05 |
| Normal-vs-Stage4 |
6.559700E-02 |
| Stage1-vs-Stage2 |
6.007400E-01 |
| Stage1-vs-Stage3 |
1.361210E-03 |
| Stage1-vs-Stage4 |
1.075040E-01 |
| Stage2-vs-Stage3 |
4.595600E-02 |
| Stage2-vs-Stage4 |
1.386380E-01 |
| Stage3-vs-Stage4 |
3.692000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58010049489121E-10 |
| Normal-vs-AfricanAmerican |
2.421200E-04 |
| Normal-vs-Asian |
3.324000E-02 |
| Caucasian-vs-AfricanAmerican |
2.256600E-01 |
| Caucasian-vs-Asian |
5.443000E-01 |
| AfricanAmerican-vs-Asian |
1.780820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.01739999442452E-10 |
| Normal-vs-Female |
4.67010000004819E-07 |
| Male-vs-Female |
1.814430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.595910E-02 |
| Normal-vs-Extreme_Weight |
1.75619999986942E-07 |
| Normal-vs-Obese |
1.87019999997595E-06 |
| Normal-vs-Extreme_Obese |
1.132230E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.178800E-01 |
| Normal_Weight-vs-Obese |
8.452800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.634000E-02 |
| Extreme_Weight-vs-Obese |
3.638200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.332500E-02 |
| Obese-vs-Extreme_Obese |
2.238600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.161000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.57729999950007E-07 |
| Normal-vs-Age(61-80Yrs) |
6.36590000047121E-07 |
| Normal-vs-Age(81-100Yrs) |
1.986030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.684230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.081700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.398000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.473600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.249900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.072400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.23979781575213E-11 |
| Normal-VS-Type2 PRCC |
5.365100E-04 |
| Normal-VS-KIRP CIMP |
9.400200E-04 |
| Normal-VS-Unclassified PRCC |
1.343070E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.550100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.563400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.598810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.880500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.613800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.360500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.803300E-04 |
| Normal-vs-N1 |
2.608000E-04 |
| Normal-vs-N2 |
7.343700E-02 |
| N0-vs-N1 |
4.181000E-03 |
| N0-vs-N2 |
1.682550E-01 |
| N1-vs-N2 |
4.761800E-01 |
|
|
